0 381

Cited 0 times in

ASO Author Reflections: Is it Correct to Use 5% Dextrose Solution as a Carrier Fluid for Oxaliplatin-based HIPEC?

DC Field Value Language
dc.contributor.author백승혁-
dc.contributor.author박은정-
dc.date.accessioned2022-12-22T05:18:30Z-
dc.date.available2022-12-22T05:18:30Z-
dc.date.issued2022-12-
dc.identifier.issn1068-9265-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/192357-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherSpringer-
dc.relation.isPartOfANNALS OF SURGICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHCytoreduction Surgical Procedures-
dc.subject.MESHGlucose-
dc.subject.MESHHumans-
dc.subject.MESHHyperthermia, Induced*-
dc.subject.MESHHyperthermic Intraperitoneal Chemotherapy*-
dc.subject.MESHOxaliplatin-
dc.titleASO Author Reflections: Is it Correct to Use 5% Dextrose Solution as a Carrier Fluid for Oxaliplatin-based HIPEC?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorEun Jung Park-
dc.contributor.googleauthorSung-Joo Hwang-
dc.contributor.googleauthorSeung Hyuk Baik-
dc.identifier.doi10.1245/s10434-022-12440-0-
dc.contributor.localIdA01827-
dc.contributor.localIdA04572-
dc.relation.journalcodeJ00179-
dc.identifier.eissn1534-4681-
dc.identifier.pmid36001184-
dc.identifier.urlhttps://link.springer.com/article/10.1245/s10434-022-12440-0-
dc.contributor.alternativeNameBaik, Seung Hyuk-
dc.contributor.affiliatedAuthor백승혁-
dc.contributor.affiliatedAuthor박은정-
dc.citation.volume29-
dc.citation.number13-
dc.citation.startPage8593-
dc.citation.endPage8594-
dc.identifier.bibliographicCitationANNALS OF SURGICAL ONCOLOGY, Vol.29(13) : 8593-8594, 2022-12-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.